- Home
- ALLO vs DDI Comparison
ALLO vs DDI Comparison
Compare ALLO & DDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALLO | DDI |
|---|---|---|
| Founded | 2017 | 2008 |
| Country | United States | South Korea |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 707.6M | 594.1M |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ALLO | DDI |
|---|---|---|
| Price | $2.06 | $11.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 2 |
| Target Price | $8.35 | ★ $19.00 |
| AVG Volume (30 Days) | ★ 7.8M | 105.8K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.65 |
| Revenue Next Year | $142,416.42 | $2.64 |
| P/E Ratio | ★ N/A | $4.31 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.99 | $8.10 |
| 52 Week High | $4.46 | $12.35 |
Technical Indicators
Market Signals| Indicator | ALLO | DDI |
|---|---|---|
| Relative Strength Index (RSI) | 52.33 | 47.82 |
| Support Level | $1.85 | $11.25 |
| Resistance Level | $2.36 | $12.30 |
| Average True Range (ATR) | 0.13 | 0.29 |
| MACD | 0.03 | -0.10 |
| Stochastic Oscillator | 74.12 | 12.00 |
Price Performance
Historical ComparisonAbout ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
About DDI DoubleDown Interactive Co. Ltd. American Depository Shares
DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. The company's operating segments include the social casino games segment and the iGaming segment. The company generates the majority of its revenue from social casino games. Geographically, the company generates the majority of its revenue from the United States, while it also has its presence in Canada, Germany, United Kingdom, and International-Other. The games offered by the company are: Doubledown Casion, Doubledown Fortknox, and Doubledown Classic Slots.